28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-000276-23-GB (EUCTR)	06/12/2016	11/07/2016	Study to look at the affect of anti-SAP treatment in patients with cardiac amyloidosis	A multiple treatment session, open label phase 2 clinical study of GSK2398852administered following ...	Systemic amyloidosis MedDRA version: 20.0;Level: SOC;Classification code 10021428;Term: Immune syste ...	Product Name: GSK2315698 Product Code: GSK2315698 INN or Proposed INN: miridesap Other descriptive name ...	GlaxoSmithKline Research & Development Ltd	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;United Kingdom
2	NCT01777243 (ClinicalTrials.gov)	May 13, 2013	24/1/2013	A Study to Evaluate the Safety of GSK2398852When Co-administered With GSK2315698 in Patients With Sy ...	A Single Dose First in Human Study of GSK2398852Co-Administered With GSK2315698 in Patients With Sys ...	Amyloidosis	Drug: GSK2398852;Drug: GSK2315698	GlaxoSmithKline	Imperial College London;Heart Hospital;Royal Free Hospital NHS Foundation Trust;Quintiles, Inc.	Completed	18 Years	70 Years	All	25	Phase 1	United Kingdom

First Previous1Next Last